カワムラ ヒデマサ   KAWAMURA Hidemasa
  河村 英将
   所属   埼玉医科大学  医学部 総合医療センター 放射線科(画像診断・核医学科、放射線腫瘍科)
   職種   教授
論文種別 学術雑誌(原著)
言語種別 英語
査読の有無 査読あり
表題 Skin Dose Reduction by Layer-Stacking Irradiation in Carbon Ion Radiotherapy for Parotid Tumors
掲載誌名 正式名:Frontiers in Oncology
ISSNコード:2234-943X
掲載区分国外
出版社 Frontiers Media SA
巻・号・頁 10,1396-1396頁
著者・共著者 Nobuteru Kubo,Yoshiki Kubota,Takahiro Oike,Hidemasa Kawamura,Makoto Sakai,Ayaka Imamura,Shuichiro Komatsu,Yuhei Miyasaka,Hiro Sato,Atsushi Musha,Naoko Okano,Katsuyuki Shirai,Jun-ichi Saitoh,Kazuaki Chikamatsu,Tatsuya Ohno
発行年月 2020/08/14
概要 Background: Layer-stacking irradiation (LSI) results in the accumulation of multiple small spread-out Bragg peaks along the beam direction. Although the superiority of LSI to conventional passive irradiation (CPI) regarding normal tissue sparing is theoretically evident, the clinical benefit of LSI has not been demonstrated. Here, we compared LSI with CPI using the same treatment planning-computed tomography images used for carbon ion radiotherapy (CIRT). Methods: Twenty-one parotid tumors were analyzed. The clinical target volume (CTV) 1 and CTV2 encompassed the parotid grand and the tumor, respectively. CTV1 and CTV2 received 36 Gy (RBE: relative biological effectiveness) in nine fractions and 64 Gy (RBE) in 16 fractions, respectively, using either LSI or CPI. CTV coverage was assessed by DX%, which is the dose covering at least X% of the target volume. Skin dose was assessed by SX, which is the skin surface area receiving at least X Gy (RBE). Results: For CTV1 and CTV2, there were no significant differences in D2% between LSI and CPI. D50% and D98% were slightly higher for CPI; however, the absolute difference between the two methods was <3%. S10-S60 (in increments of 10) were significantly lower for LSI than for CPI (P < 0.001 for all parameters). LSI was associated with a significant trend toward dose reduction at the skin area irradiated with a higher dose by CPI (P < 0.001). Conclusions: LSI achieved better skin sparing than CPI without sacrificing target volume coverage in parotid tumor patients.
DOI 10.3389/fonc.2020.01396
PMID 32923391
PermalinkURL https://www.frontiersin.org/article/10.3389/fonc.2020.01396/full